Ortec Obtains Second U.S. Patent Allowance on Haptide Cell Attachment Technology
Ortec Obtains Second U.S. Patent Allowance on Haptide Cell Attachment Technology
RedNova - Sep 20 1:09 PM
NEW YORK, Sept. 20 /PRNewswire-FirstCall/ — Ortec International, Inc. (BULLETIN BOARD: OTCI) , a company focused on advancing regenerative medicine through the development of cellular technology and advanced biomaterial products, has received notification from the U.S.Save to My Web
FDA Warns that Popular US Anti-Aging Ingredient Used for Age Spots May be a Carcinogen in Humans; Customized Skin Care
[Press Release] PR Web - Sep 21 12:27 AM
(PRWEB Sep 21, 2006) Trackback URI: http://www.prweb.com/dingpr.php/Q3Jhcy1Mb3ZlLUxvdmUtSG9yci1JbnNlLVplcm8=Save to My Web